Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
Open Access
- 1 November 1999
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 10 (11) , 1301-1305
- https://doi.org/10.1023/a:1008350518083
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Neoadjuvant cisplatin,methotrexate,and vinblastine chemotherapy for muscle-invasive bladder cancer: a randomised controlled trialThe Lancet, 1999
- Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome.Journal of Clinical Oncology, 1998
- Bladder preservation by combined modality therapy for invasive bladder cancer.Journal of Clinical Oncology, 1997
- Five-year Followup of a Prospective Trial of Radical Cystectomy and Neoadjuvant Chemotherapy: Nordic Cystectomy Trial 1Journal of Urology, 1996
- NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN ADVANCED DISEASE?WHAT ARE THE EFFECTS ON SURVIVAL AND PROGNOSIS?International Journal of Urology, 1995
- Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladderCancer, 1993
- Staging invasive bladder tumorsJournal of Surgical Oncology, 1992
- The Prognostic Value of the Pathological Response to Combination Chemotherapy before Cystectomy in Patients with Invasive Bladder CancerJournal of Urology, 1992
- Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapseCancer, 1989
- Neo‐adjuvant Chemotherapy for Invasive Bladder Cancer. Experience with the M‐VAC RegimenBritish Journal of Urology, 1989